Search results
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly - Eli Lilly and Co...
Benzinga· 3 days agoEvery day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks· 4 days ago(LLY Quick QuoteLLY - Free Report) . Of these, at present, Eli Lilly appears to be a great stock to have in one's portfolio based on its strong overall financial performance ...
Behind the Scenes of Intellia Therapeutics's Latest Options Trends - Intellia Therapeutics...
Benzinga· 4 days agoPresent Market Standing of Intellia Therapeutics Trading volume stands at 742,147, with NTLA's price down by -0.65%, positioned at $24.64. RSI indicators show the
Top Three Swiss Dividend Stocks For June 2024
Simply Wall St. via Yahoo Finance· 5 days agoThe Switzerland market displayed modest gains on Wednesday, navigating through a volatile trading session as investors awaited key policy decisions from...
McKesson (MCK) Introduces FDA-Approved Prostate Cancer Drug
Zacks· 5 days agoThe availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is...
Sarepta surges as investors cheer expanded use of gene therapy
Reuters via Yahoo News· 4 days ago(Reuters) -Sarepta Therapeutics shares surged as much as 40% to a more than three-year high on Friday as an expanded use approval cemented its dominant position in the gene therapy market for ...